Skip to Content

← See all Pink Bismuth brands

Pink Bismuth by Preferred Pharmaceuticals, Inc

Dosage form: tablet, chewable
Ingredients: BISMUTH SUBSALICYLATE 262mg
Labeler: Preferred Pharmaceuticals, Inc
NDC Code: 68788-0190

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug label

Active Ingredient

Bismuth subsalicylates 262mg...........Antidiarrheal/Antacid

Uses

Controls diarrhea
relieves heartburn, indigestion, nasea and upset stomach without constipating

Reye's syndrome

Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea or vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.

Allergy alert

Contains salicylate. Do not take if you are

allergic to salicylates (including aspirin)
taking other salicylate products

Do not use if you have

an ulcer
a bleeding problem
bloody or black stool

Ask a doctor before use if you have

fever
mucus in the stool

Ask a doctor or pharmacist before use if you are taking any drug for

anticoagulation (thinning the blood)
diabetes
gout
arthritis

When using this product a temporary, but harmless, darkening of the stool and/or tongue may occur.

Stop use and ask a doctor if

symptoms get worse
ringing in the ears or loss of hearing occurs
diarrhea lasts more than 2 days

If pregnant or breast-feeding, ask a health professional before use.

Dosage and Administration

Adults and Children 12 years and over: 525mg (2 tablets) every 1/2 to 1 hour or 1050mg (4 tablets) every hours as needed.  Do not exceed 4200mg (16 tablets) in 24 hours.  Use until diarrhea stops but not more than 2 days.  Children under 12 years ask a doctor

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Adults and Children 12 years and over: 525mg (2 tablets) every 1/2 to 1 hour or 1050mg (4 tablets) every hours as needed.  Do not exceed 4200mg (16 tablets) in 24 hours.  Use until diarrhea stops but not more than 2 days.  Children under 12 years ask a doctor

Other information:

Save carton for full directions and warnings
Store at controlled room temperature 59°- 86°F (°15 - 30°C)
Do not use is cellophane unit is torn, cut or open.
Phenylketonurics: Contains phenylalanine 1.1mg per tablet.
Calcium content per tablet, 73mg

aspatame, calcium carbonate, D and C red #27, dextrates, flavor, magnesium stearate, microcrystalline cellulose, silicon dioxide

Image for Pink Bismuth Label

PINK BISMUTH 
bismuth subsalicylate tablet, chewable
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68788-0190(NDC:0603-0235)
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BISMUTH SUBSALICYLATE (SALICYLIC ACID) BISMUTH SUBSALICYLATE262 mg
Inactive Ingredients
Ingredient NameStrength
ASPARTAME 
CALCIUM CARBONATE 
DEXTRATES 
MAGNESIUM STEARATE 
SILICON DIOXIDE 
Product Characteristics
Colorpink (Pink) Scoreno score
ShapeROUNDSize15mm
FlavorImprint CodeRH046
Contains    
Packaging
#Item CodePackage Description
1NDC:68788-0190-330 TABLET, CHEWABLE in 1 BOX
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart33512/01/2010
Labeler - Preferred Pharmaceuticals, Inc (791119022)
Registrant - Preferred Pharmaceuticals, Inc (791119022)
Establishment
NameAddressID/FEIOperations
Preferred Pharmaceuticals, Inc791119022REPACK(68788-0190)

Revised: 12/2017
 
Preferred Pharmaceuticals, Inc

← See all Pink Bismuth brands

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide